<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">

  <head>
    <title>Special Blood Components</title>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="stylesheet" href="http://code.jquery.com/mobile/1.4.4/jquery.mobile-1.4.4.min.css" />
    <link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css">
    <link rel="stylesheet" href="app.css">
    <link href="http://themergency.com/footable-demo/css/footable-0.1.css" rel="stylesheet" type="text/css" />
    <link href="http://themergency.com/footable-demo/css/footable.sortable-0.1.css" rel="stylesheet" type="text/css" />
  </head>

  <body>
    
    <div class="overlay">
    	
    	<div class="overlay-container" id="terms">
        <h3 class="headerlogo"><i class="fa fa-ln glow">&#xf043;</i> Special Blood Components Terms of Use
        </h3>
    		<div class="textbox">
        <p><strong>
    		 By pressing the 'Accept and continue' button, you indicate that you have
    		 read and consent to the Terms of Use.</strong>
    		</p>
    		<h3>Terms of Use</h3>
        <h4>
          Purpose and audience
        </h4>
        <p>
          Special Blood Components ("the app") aims to make it easy to learn about
          the correct use of irradiated and cytomegalovirus (CMV) negative blood
          components in patients with special transfusion requirements.
          It is designed for:
        </p>
        <ul>
          <li>Doctors who prescribe and request blood transfusions.
          </li>
          <li>Nurses and midwives who administer or prescribe transfusions.
          </li>
          <li>Biomedical scientists who process blood requests.
          </li>
          <li>Medical trainees who may be required to undertake any of the above.
          </li>
        </ul>
        
        <h4>
          Evidence base
        </h4>
        
        <p>
          The app is based on the British Committee for Standards in Haematology (BCSH)
          2010 guidelines on the irradation of blood components and the 2012 position 
          statement on the use of CMV negative blood components by the Advisory 
          Committee on the Safety of Blood, Tissues and Organs (SaBTO).
        </p>
        
        <h4>
          Data protection
        </h4>
        
        <p>
          The app is developed as part of a research project seeking to evaluate and improve the design
          of medical apps. The use of the app is therefore monitored using Google Analytics.
          To do this we store a browser cookie on your device. The following data is recorded:
        </p>
        
        <ul> 
          <li>Which pages you visit and for how long.</li>
          <li>Information about your computing device (operating system, screen resolution, browser, IP address).</li>
          <li>Your approximate geographical location (country, city).</li>
        </ul>
        
        <p>
          This data is only available to the researchers, but analysis of the data
          may be presented in academic publications observing academic good practice,
          such as protecting confidentiality through pseudonymisation and anonymisation.
        </p>
        
        <h4>
          Disclaimer
        </h4>
        
        <p>
          The app was created during a PhD research project at the University of 
          Edinburgh and is available for evaluation only. There may be inaccuracies in 
          the content. Guidance may not be appropriate in all patient situations and
          local hospital policies may differ.</p>
          
        <p> 
          The app is not intended to be a substitute for local hospital guidelines,
          professional medical judgement, advice, diagnosis, or treatment. The app
          publishers, developers and contributors do not take any legal resposibility
          for harm resulting from the use of the app. Use your own critical judgement
          and always put patient safety first.
        </p>
        
        <h4>No warranty</h4>
        
        <p>
          THE APP IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
          IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
          FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
          AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
          LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
          OUT OF OR IN CONNECTION WITH THE APP OR THE USE OR OTHER DEALINGS IN THE
          APP.
        </p>
    		</div>
    		<a href="#" onclick="$('.overlay').slideUp('slow');" class="ui-btn ui-shadow ui-corner-all ui-btn-a">Accept and continue</a>
  		</div>
  	</div>
  	
  	
    <div data-role="page" id="home" data-title="Special Blood Components">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf043;</i> Special Blood Components Home
        </h3>
        <div class="submenu inactive hidden">
          <p style="margin: 0;">
          v.0.2. Updated 5/11/2015
            <a href="#searchdialog" data-rel="dialog" data-transition="slidedown" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
          </p>
        </div>
      </div>

      <div role="main" class="ui-content">
    
    		<h2 class="mainlogo hidden">
    		  <i class="fa fa-5x glow">&#xf043;</i>
          <br/>Special Blood Components
        </h2>

        <a data-role="button" href="#indications" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf0f1;</i>
           <strong>Indications</strong><br/>
           Which patients require irradiated or CMV-negative blood components?
        </a>
        
        <a data-role="button" href="#learn" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf19d;</i>
           <strong>Rationale</strong><br/>
           Why provide irradiated or CMV-negative blood to patients with special requirements?
        </a>
        
        <a data-role="button" href="#searchpanel" class="infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf002;</i>
           <strong>Search the app</strong><br/>
           Find all occurances of a term across the app.
        </a>
        
        <a data-role="button" href="#glossary" class="infobox hidden">
           <i class="fa fa-fw fa-2x button-icon">&#xf02e;</i>
           <strong>Glossary</strong><br/>
           Look up a word in the index.
        </a>
        
        <a data-role="button" href="#references" class="hidden infobox">
           <i class="fa fa-fw fa-2x button-icon">&#xf02d;</i>
           <strong>References</strong><br/>
           Browse evidence cited in the app.
        </a>
        
        <a data-role="button" href="#about"  class="infobox">
           <i class="fa fa-2x button-icon">&#xf05a;</i>
           <strong>About the app</strong><br/>
           Find out more details about this app.
        </a>
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab active"><i class="fa fa-2x glow">&#xf015;</i> Home</a>
            </li>
            <li><a href="#learn" class="navtab inactive"><i class="fa fa-2x">&#xf19d;</i>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i> Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn" data-title="Learn about Special Blood Components">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Rationale: Learning objectives
        </h3>
        <div class="submenu inactive">
          <a href="#home" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#ta-gvhd" data-role="button">Next <i class="fa fa-ln">&#xf054;</i></a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
      
        <h2>Rationale</h2>
      
      
        <p>
          This section explains how the risk of TA-GvHD and TT-CMV infection
          is managed through the use of irradiated, leucodepleted and
          CMV-negative blood components.
            
        </p>
        
        <h3>1.1 Learning objectives</h3>
        
        <p>Reviewing the information in this section will provide a better understanding of the following topics:
        </p>
        <ul>
          <li><p><span class="explanation" title="Transfusion Associated Graft versus Host Disease">TA-GvHD</span> is a rare lethal complication of transfusion.</p></li>
          <li><p><span class="explanation" title="Irradiation inactivates donor lymphocytes that cause TA-GvHD.">Gamma or x-ray irradiation</span> is the accepted way of preventing TA-GvHD.</p></li>
          <li><p>Transfusion can transmit <span class="explanation" title="Cytomegalovirus">CMV</span> infection, leading to fatal or serious conditions in vulnerable patients.</p></li>
          <li><p>CMV-negative blood is indicated for intra-uterine and neonatal transfusions, elective transfusions during pregnancy and granulocyte transfusions to CMV-negative patients.</p></li>
          <li><p>For all other patients, leucodepletion provide sufficient protection against CMV.</p></li>
          <li><p>Mistakes can frequently lead to patients with special requirements not receiving irradiated or CMV-negative blood components.</p></li>
        </ul>
        
        
        <a href="#home" style="padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#ta-gvhd" style="float:right; padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
        
        <h3>Navigation</h3>
        
        <p>Select a topic below to jump to that section or use the back and next navigation buttons.</p>
        
        <a href="#" style="padding: 0.8em;" data-role="button" data-theme="b" class="hidden active" onclick="$('.toc').toggle('slow');"><i class="fa fa-ln">&#xf0c9;</i> Table of contents</a>
       
        <div class="toc">
          <ul data-role="listview" data-inset="true" data-dividertheme="b">
            <li data-theme="b"><a href="#learn" class="active" data-theme="b">1.1 Learning objectives</a></li>
            <li><a href="#ta-gvhd">1.2 Transfusion-associated Graft versus Host Disease</a></li>
            <li><a href="#tt-cmv">1.3 Transfusion-transmitted Cytomegalovirus infection</a></li>
            <li><a href="#error">1.4 Errors in provision of special requirements</a></li>
            <li><a href="#summary">1.5 Summary</a></li>
            <li><a href="#reference">1.6 Further reading</a></li>
          </ul>
        </div>
        
        <a href="#" data-role="button" data-theme="b" onclick="$(window).scrollTop(0);" class="active">Back to top <i class="fa fa-ln">&#xf0d8;</i></a>
        

      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i> Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i> Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    
    <div data-role="page" id="ta-gvhd" data-title="Learn about Special Blood Components">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> 1.2 Transfusion-Associated Graft versus Host Disease (TA-GvHD)
        </h3>
        <div class="submenu inactive">
          <a href="#learn" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#tt-cmv" data-role="button">Next <i class="fa fa-ln">&#xf054;</i></a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h2>1.2 Transfusion-Associated Graft versus Host Disease (TA-GvHD)</h2>
        
        <p>
          TA-GvHD is a very rare fatal disease caused by the transfusion of cellular
          blood components (red cells, platelets and granulocytes) containing
          viable lymphocytes. Unless destroyed, the transfused donor lymphocytes can 
          engraft and attack the recipient, causing skin rash, diarrhoea, liver disease,
          bone marrow failure and death from infection within a month of the transfusion.
          Fortunately the recipient's immune system normally identify the
          transfused donor lymphocytes as foreign and destroy them.
        </p>
        
        <h3>Risk factors and prevention</h3>

        <p>
          The success of the recipient's immune response depends on three factors (BCSH 2010, p.37):
        </p>
        
        <ul>
          <li><p>The number and viability of lymphocytes transfused.</p></li>
          <li><p>The susceptibility of the recipient's immune system to their engraftment.</p></li>
          <li><p>The degree of immunological (HLA) disparity between donor and patient.</p></li>
        </ul>
        
        <h3>Reducing the number of lymphocytes through leucodepletion</h3>
        
        <p>
          All platelets and red cells blood are leucodepleted in the UK, significantly
          reducing the number of lymphocytes. Only two cases of TA-GvHD have been 
          reported in the UK following the introduction of universal leucodepletion,
          despite several hundred reports patients failing to be provided with irradiated
          blood products. This suggest leucodepletion is effective in reducing the risk
          of TA-GvHD, although it is not a replacement for irradiation.
        </p>
        
        <h3>Inactivating donor lymphocytes through irradiation</h3>
        
        <p>
          Irradation is the only method known to prevent TA-GvHD.
          Fortunately the recipient's immune system normally identify the
          transfused donor lymphocytes as foreign and destroy them. The risk of
          TA-GvHD is higher when the recipient's immune response is ineffective,
          such as in patients with severe immunodeficiency. These patients should
          receive irradiated blood components.
          
          TA-GvHD can also occur in immunocompetent recipients if their immune
          system is unable to identify the donor lymphocytes.
        </p>
        
        
        <h3>Indications for irradiated blood components</h3>
        
        <p>
        
          Only cellular blood components given to at risk patients.
          
          Granulocytes cannot be leucodepleted and is full of active lymphocytes.
  
          Only cellular blood components contain lymphocytes. Fresh Frozen Plasma
          (FFP), cryoprecipitate and plasma products do not need to be irradiated.
          (BCSH 2010, p.36)
      
        </p>
        
        <h3>Immunodeficiency</h3>
        
        
        <h3>Immunological disparity (HLA)</h3>
        
        <p>
          Identification depends on differences in the human leucocyte antigens 
          (HLA) between donor and recipient. TA-GvHD occurs when there is a one way 
          HLA match between the donor and recipient, which can occur in transfusions
          between relatives or HLA-matched transfusions (see figure).
        </p>

        <a href="#" data-role="button" data-inline="true" onclick="$('#hla-figure').toggle('slow')">Figure: One way HLA match</a>
        
        <div class="hidden" id="hla-figure">
          
          <p>Click image to change size.</p>
          
          <div style="overflow-x: scroll;">
            <img onclick="$(this).toggleClass('big-image').toggleClass('small-image')" class="small-image" src="hla-vertical.png"/>
          </div>
          
          <p style="line-height: 1.1em;">
            The blood donor is homozygous for an HLA haplotype (red) for which the 
            recipient is heterozygous (red and blue).
          </p>
        </div>
        
        <h3>Navigation</h3>
        
        <a href="#" style="padding: 0.8em;" data-role="button" data-theme="b" class="hidden active" onclick="$('.toc').toggle('slow');"><i class="fa fa-ln">&#xf0c9;</i> Table of contents</a>
       
        <div class="toc">
          <ul data-role="listview" data-inset="true" data-dividertheme="b">
            <li><a href="#learn">1.1 Learning objectives</a></li>
            <li data-theme="b"><a href="#ta-gvhd" class="active">1.2 Transfusion-associated Graft versus Host Disease</a></li>
            <li><a href="#tt-cmv">1.3 Transfusion-transmitted Cytomegalovirus infection</a></li>
            <li><a href="#error">1.4 Errors in provision of special requirements</a></li>
            <li><a href="#summary">1.5 Summary</a></li>
            <li><a href="#reference">1.6 Further reading</a></li>
          </ul>
        </div>
        
        <a href="#learn" style="padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#tt-cmv" style="float:right; padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
        
        <a href="#" data-role="button" data-theme="b" onclick="$(window).scrollTop(0);" class="active">Back to top <i class="fa fa-ln">&#xf0d8;</i></a>
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i> Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i> Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    
    <div data-role="page" id="tt-cmv" data-title="Transfusion transmitted CMV infection">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> 1.3 Transfusion-Transmitted Cytomegalovirus (CMV) infection
        </h3>
        <div class="submenu inactive">
          <a href="#ta-gvhd" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#error" data-role="button">Next <i class="fa fa-ln">&#xf054;</i></a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
            
        <h2>1.3 Transfusion-Transmitted Cytomegalovirus (CMV) infection</h2>
        
          <p>
  
            Cytomegalovirus (CMV) is a herpes virus that cause a mainly asymptomatic infection in
            healthy people. About half the UK population is CMV positive (Sabto p.2) and many blood
            donors carry the virus. The virus can occur freely in the blood stream during active
            infection and it remains latent in monocytes after infection (Sabto p. 2).

          </p>
        
        <a href="#" data-role="button" data-inline="true" onclick="$('#cmv-figure').toggle('slow')">Micrograph image of CMV</a>
        
        <div class="hidden" id="cmv-figure">
          
          <p>Click image to change size.</p>
          
          <div style="overflow-x: scroll;">
            <img onclick="$(this).toggleClass('big-image').toggleClass('small-image')" class="small-image" src="cmv-tem.jpg"/>
          </div>
          
          <p style="line-height: 1.1em;">
            200x transmission electron micrograph (TEM). Cytomegalovirus is present
            as intranuclear inclusion bodies ('owl eyes'). Image credit: The CDC 
            Public Health Image Library, 1986. Image in the public domain.
          </p>
        </div>
        
        <h3>Risk groups</h3>
          
          <p>
  
            CMV infection often go unnoticed in immunocompetent patients, but it can be fatal
            or cause lifelong disability in fetuses, neonates and immunocompromised patients.
            Neonatal mortality from CMV infection is 10-30% (higher in preterms) and the virus
            accounts for 12% of all sensorineural hearing loss and 10% of cerebral palsy (Sabto p.4).

          </p>
          
          
        <h3>Prevention</h3>
        
          <p>
            Cellular blood components (red cells, platelets and granulocytes) may contain CMV infected
            monocytes which can transmit the virus if transfused. Infection is prevented by avoiding 
            unnecessary transfusions, removing white cells from red cells and platelets 
            through leucodepletion and using blood from donors who screen negative for CMV antibody.
          </p>

        <h3>Leucodepletion</h3>

        <p>
          Leucodepletion is the removal of white cells, usually by filtration, from red cells and
          platelets. This process is particularly effective in removing monocytes, white cells where 
          CMV may be latent (sabto p.2). Since 1999 all platelets and red cells produced in the UK are 
          leucodepleted. Universal leucodepletion has significantly reduced the risk of 
          transfusion-transmitted CMV infection, but the risk is not completely eliminated (Sabto).
          For this reason patients at high risk should receive blood from CMV-negative donors.
        </p>

        <h3>Who should receive CMV-negative blood?</h3>

        <p>
          CMV-negative blood is indicated for intra-uterine and neonatal transfusions 
          (up to 28 days post expected date of delivery). There is a high chance of
          congenital CMV infection if a pregnant women gets infected or re-infected.
          Pregnant women, regardless of their CMV serostatus, who receive multiple 
          elective transfusions should receive CMV-negative blood. But it is not 
          required during labour and delivery. In an emergency where CMV-negative
          blood is unavailable, leucodepleted blood should be used. Finally,
          CMV-negative components should be provided to seronegative patients
          receiving granulocytes.
        </p>

        <p>
          For all other patients, including patients with HIV, solid organ transplant
          and haemopoetic stem cell transplant patients, leucodepletion confers sufficient
          protection against CMV infection (Sabto). 
        </p>
        
        <h3>Navigation</h3>
        
        <a href="#" style="padding: 0.8em;" data-role="button" data-theme="b" class="hidden active" onclick="$('.toc').toggle('slow');"><i class="fa fa-ln">&#xf0c9;</i> Table of contents</a>
       
        <div class="toc">
          <ul data-role="listview" data-inset="true" data-dividertheme="b">
            <li><a href="#learn">1.1 Learning objectives</a></li>
            <li><a href="#ta-gvhd">1.2 Transfusion-associated Graft versus Host Disease</a></li>
            <li data-theme="b"><a href="#tt-cmv" class="active">1.3 Transfusion-transmitted Cytomegalovirus infection</a></li>
            <li><a href="#error">1.4 Errors in provision of special requirements</a></li>
            <li><a href="#summary">1.5 Summary</a></li>
            <li><a href="#reference">1.6 Further reading</a></li>
          </ul>
        </div>
        
        <a href="#ta-gvhd" style="padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#error" style="float:right; padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
        
        <a href="#" data-role="button" data-theme="b" onclick="$(window).scrollTop(0);" class="active">Back to top <i class="fa fa-ln">&#xf0d8;</i></a>
        
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i> Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i> Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    
    <div data-role="page" id="error" data-title="Mistakes involving special requirements">
      
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> 1.4 Errors in the provision of special requirements
        </h3>
        <div class="submenu inactive">
          <a href="#tt-cmv" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#summary" data-role="button">Next <i class="fa fa-ln">&#xf054;</i></a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
            
        <h2>1.4 Errors in the provision of special requirements</h2>
        
        <p>
          Almost three million blood components are issued annually in UK <a href=
          "javascript:%20showSource('shot2009');" class="reference">SHOT 2009, p.11</a>.
          Of these, approximately 10% are irradiated <a href=
          "javascript:%20showSource('shot2010');" class="reference">SHOT 2010, p.129</a>.
        </p>
        <p>
          In the last five years, more than five hundred mistakes involving irradiated
          and CMV negative blood components were reported to the Serious Hazards of
          Transfusion (SHOT) UK haemovigilance scheme (Figure 1).
        </p>
        <p>
          These were incidents where blood components failed to be provided as irradiated
          and/or CMV negative to at-risk patients according to guidelines.
        </p>
        
        <a href="#" data-role="button" onclick="$('#errorgraph').toggle('slow')">Graph of mistakes reported to SHOT.</a>
        
        <div class="hidden" id="errorgraph">
          
          <p>Click image to change size.</p>
          
          <div style="overflow-x: scroll;">
            <img onclick="$(this).toggleClass('big-image').toggleClass('small-image')" class="small-image" src="http://optimalblooduse.eu/app/graph.png"/>
          </div>
          
          <p style="line-height: 1.1em;">
            <b>Figure 1:</b> Specific Requirements Not Met (SRNM) reports by year and
            source of error. Clinical errors include failure to communicate the need for
            special components to the lab. Lab errors are when the request was made but not
            acted upon <a href="javascript:%20showSource('shot2010');" class=
            "reference">SHOT 2010, p.27</a>. SHOT data used with permission and provided
            courtesy of Dr. Paula Bolton-Maggs, Debbi Poles and Alison Watts.
          </p>
        </div>
        
        <h3>Navigation</h3>
        
        <a href="#" style="padding: 0.8em;" data-role="button" data-theme="b" class="hidden active" onclick="$('.toc').toggle('slow');"><i class="fa fa-ln">&#xf0c9;</i> Table of contents</a>
       
        <div class="toc">
          <ul data-role="listview" data-inset="true" data-dividertheme="b">
            <li><a href="#learn">1.1 Learning objectives</a></li>
            <li><a href="#ta-gvhd">1.2 Transfusion-associated Graft versus Host Disease</a></li>
            <li><a href="#tt-cmv">1.3 Transfusion-transmitted Cytomegalovirus infection</a></li>
            <li data-theme="b"><a href="#error" class="active">1.4 Errors in provision of special requirements</a></li>
            <li><a href="#summary">1.5 Summary</a></li>
            <li><a href="#reference">1.6 Further reading</a></li>
          </ul>
        </div>
        
        <a href="#tt-cmv" style="padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#summary" style="float:right; padding: 0.8em;" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
        
        <a href="#" data-role="button" data-theme="b" onclick="$(window).scrollTop(0);" class="active">Back to top <i class="fa fa-ln">&#xf0d8;</i></a>
        
        
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i> Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i> Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    
    <div data-role="page" id="learn1" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1. Introduction
        </h3>
        <div class="submenu inactive">
          <a href="#home" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn2" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        <div class="hidden">
          <h2>1. Introduction</h2>
          <ul>
            <li>Learning outcomes</li>
            <li>Summary of key points</li>
            <li>TA-GvHD and irradiation</li>
            <li>CMV infection and screening</li>
            <li>Mistakes and their prevention</li>
            <li>Test your knowledge</li>
            <li>Glossary</li>
            <li>Learning resources</li>
            <li>References</li>
          </ul>
          
          <h3>Key learning points</h3>
          <p>You have completed the section. Summary of the key learning points:</p>
          <ul>
            <li><p>Transfusion associated graft versus host disease (TA-GvHD) is a rare fatal complication of transfusion that is preventable by irradiating components.</p></li>
            <li><p>Transfusion of Cytomegalovirus (CMV) positive blood can cause life long disability in vulnerable patients (e.g. neonates and fetuses) who should receive components tested negative to CMV (CMV-negative).</p></li>
          </ul>
        </div>
        
        <h3>
          1.1 Patient safety
        </h3>
        <p>
          Failure to provide <a href="javascript:%20showWord('irradiation')" class=
          "definition">irradiated</a> cellular <a href=
          "javascript:%20showWord('components')" class="definition">blood components</a>
          may expose <a href="javascript:showWord('at-risk')" class="definition">at-risk
          patients</a> to transfusion-associated Graft versus Host Disease <a href=
          "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. This is a very
          rare, but life-threatening condition <a href=
          "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010, p.37</a>.
        </p>
        <p>
          Red cells and platelets supplied through the UK Blood Services are <a href=
          "javascript:%20showWord('leucodepletion')" class="definition">leucocyte
          depleted</a> <a href="javascript:%20showSource('bcsh2010');" class=
          "reference">SaBTO 2012, p.1</a>. However removal of leucocytes (white cells) is
          not a substitute for irradiation, which prevents TA-GvHD by inactivating residual
          donor lymphocytes <a href="javascript:%20showSource('bcsh2010');" class=
          "reference">BCSH 2010, p.49</a>.
        </p>
        <p>
          Although leucodepletion provides significant protection against <a href=
          "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a> (CMV)
          infection, cellular blood components should be provided as CMV negative to
          protect vulnerable patients against transfusion-transmitted CMV infection
          <a href="javascript:%20showSource('sabto2012');" class="reference">SaBTO
          2012</a>.
        </p>
        
        <hr/>
        <a href="#learn" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#learn2" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
       
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn2"  data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.2 Mistakes
        </h3>
        <div class="submenu inactive">
          <a href="#learn1" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn3" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.2 Mistakes
        </h3>
        <p>
          Almost three million blood components are issued annually in UK <a href=
          "javascript:%20showSource('shot2009');" class="reference">SHOT 2009, p.11</a>.
          Of these, approximately 10% are irradiated <a href=
          "javascript:%20showSource('shot2010');" class="reference">SHOT 2010, p.129</a>.
        </p>
        <p>
          In the last five years, more than five hundred mistakes involving irradiated
          and CMV negative blood components were reported to the Serious Hazards of
          Transfusion (SHOT) UK haemovigilance scheme (Figure 1).
        </p>
        <p>
          These were incidents where blood components failed to be provided as irradiated
          and/or CMV negative to at-risk patients according to guidelines.
        </p><img src="http://optimalblooduse.eu/app/graph.png" style="display: block; margin: 0 auto; width:100%;" />
        <p style="line-height: 1.1em;">
          <b>Figure 1:</b> Specific Requirements Not Met (SRNM) reports by year and
          source of error. Clinical errors include failure to communicate the need for
          special components to the lab. Lab errors are when the request was made but not
          acted upon <a href="javascript:%20showSource('shot2010');" class=
          "reference">SHOT 2010, p.27</a>. SHOT data used with permission and provided
          courtesy of Dr. Paula Bolton-Maggs, Debbi Poles and Alison Watts.
        </p>
        
        <hr/>
        <a href="#learn1" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#learn3" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
       
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-role="page" id="learn3" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.3 Causes
        </h3>
        <div class="submenu inactive">
          <a href="#learn2" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn4" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.3 Causes
        </h3>
        <p>
          There are many underlying reasons for why special requirements fail to be
          provided to at-risk patients, as these SHOT cases illustrate:
        </p>
        
        <div data-role="collapsible-set" data-iconpos="right" data-theme="b" data-content-theme="a">
          <div data-role="collapsible">
            <h3>
              Poor knowledge of the indications
            </h3>
            <p>
              "The admitting doctor noted the past history of Hodgkin's disease but was
              not aware of the requirements for irradiated blood." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" >
            <h3>
              Request form not filled out correctly
            </h3>
            <p>
              "A request form for blood components for a patient with CLL on fludarabine
              was completed by a haematology nurse, and checked and signed by a junior
              doctor who also prescribed the components. The need for irradiated blood
              was not indicated on the request form or the prescription." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.46</a>
            </p>
          </div>
          <div data-role="collapsible" >
            <h3>
              Failure to check medical record
            </h3>
            <p>
              "An elderly man was transfused 9 units of blood for chronic anaemia.
              Subsequently a haematology registrar found that he had been treated with
              cladarabine several years before." <a href=
              "javascript:%20showSource('shot2012');" class="reference">SHOT 2012,
              p.32</a>
            </p>
          </div>
          <div data-role="collapsible" >
            <h3>
              Shared patient care
            </h3>
            <p>
              "A patient was transferred from his primary hospital, where he had
              undergone a stem-cell transplant, to another hospital within the same Trust
              in order to access an ITU bed. [...] Irradiated components were not
              requested due to a lack of communication between the clinicians, and the
              laboratory records were separate from those at the originating hospital."
              <a href="javascript:%20showSource('shot2010');" class="reference">SHOT
              2010, p.41</a>
            </p>
          </div>
          <div data-role="collapsible" >
            <h3>
              Wrong blood component transfused
            </h3>
            <p>
              "No patient identification was taken to the blood fridge, and as a result
              the wrong unit of red cells was removed by a registered nurse and taken to
              the ward for an 81-year-old female patient with chronic lymphocytic
              leukaemia (CLL). On the ward another nurse administering the transfusion
              assumed that the checks had been completed, and because of this assumption
              no bedside checks were performed. The patient received non-irradiated group
              A D positive red cells, instead of irradiated O D positive red cells. The
              error was noticed when the patient asked whether the unit was irradiated.
              Consequently &lt;50 mL was transfused." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.31</a>
            </p>
          </div>
          <div data-role="collapsible" >
            <h3>
              Incorrect use of warning flags
            </h3>
            <p>
              "A patient required irradiated blood because of previous chemotherapy. The
              transfusion laboratory had received notification of this special
              requirement and added the information to the LIMS. The special requirement
              flag was subsequently removed from the LIMS in error. From the time the
              flag was removed to the time it was discovered, the patient had received 15
              units of red cells and 5 units of platelets that had not been irradiated."
              <a href="javascript:%20showSource('shot2012');" class="reference">SHOT
              2012, p.56</a>
            </p>
                
          </div>
          <hr/>
          <a href="#learn2" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn4" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
           
        </div>
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
      
    <div data-role="page" id="learn4" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.4 Prevention
        </h3>
        <div class="submenu inactive">
          <a href="#learn3" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn5" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.4 Prevention
        </h3>
        <p>
          SHOT has made several recommendations aimed at reducing mistakes. Some of these are to:
        </p>
        <div data-role="collapsible-set" data-theme="h" data-content-theme="h">
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Increase knowledge of special requirements
            </h3>
            <p>
              "All haematology units must devise specific educational programmes for all
              their staff members providing the rationale and indications for specialist
              components and this information should be accessible at the time of making
              the requests for blood components." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2011,
              p.28</a>
            </p>
            <p>
              "The importance of irradiation, and the rationale behind it should be
              emphasised during teaching of junior haematology and oncology doctors. This
              education is part of the curriculum for specialist trainees, but the junior
              pre-specialist doctors in these areas may remain ignorant despite being
              frequently called upon to order components." <a href=
              "javascript:%20showSource('shot2008');" class="reference">SHOT 2008,
              p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Ensure special blood components are ordered correctly
            </h3>
            <p>
              "Local mechanisms for ordering and prescribing components need to
              facilitate correct ordering, and remind clinical and laboratory personnel
              where possible" <a href="javascript:%20showSource('shot2011');" class=
              "reference">SHOT 2011, p.26</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Educate patients who have special requirements
            </h3>
            <p>
              "Patients who require irradiated and other special products should be
              provided with an appropriate card [...] Patients with cards noting special
              requirements should be educated about their meaning and importance, in
              particular always to show these to clinical staff on admission to any
              hospital." <a href="javascript:%20showSource('shot2012');" class=
              "reference">SHOT 2012, p.34</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Conduct thorough bedside checks
            </h3>
            <p>
              "The final 'bedside' check is the last opportunity to ensure that the
              correct unit or component has been collected for the patient receiving the
              transfusion. Complete and thorough bedside checks involving one or two
              staff members must be completed independently and without interruption. "
              <a href="javascript:%20showSource('shot2011');" class="reference">SHOT
              2013, p.61</a>
            </p>
            <p>
              "Every person in the transfusion process must perform rigorous identity
              checks at each point and ensure that the component collected is the one
              prescribed. The use of a transfusion checklist is recommended." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2013,
              p.62</a>
            </p>
          </div>
          <div data-role="collapsible" data-collapsed-icon="check">
            <h3>
              Use warning flags with care
            </h3>
            <p>
              "Computer prompts/warnings/flags are a valuable tool for trying to prevent
              human error through 'slips'; but staff must also have the underpinning 
              knowledge to understand and act appropriately to a warning." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.7</a>
            </p>
            <p>
              "The addition of these warnings/flags/notes is a manual procedure and is
              itself prone to error and should be controlled, for example, entered by one
              BMS and checked by a second." <a href=
              "javascript:%20showSource('shot2011');" class="reference">SHOT 2012,
              p.51</a>
            </p>
            
                
          </div>
        </div>
        <p>
          Press to expand list items.
        </p>
        <p>
          For more details and recommendations, please refer to the latest SHOT
          report. <a href="javascript:%20showSource('shot2013');" class=
          "reference">SHOT 2013</a>
        </p>
        <hr/>
        <a href="#learn3" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#learn5" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
       
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="learn5" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.5 Glossary
        </h3>
        <div class="submenu inactive">
          <a href="#learn4" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#learn6" data-role="button" class="float-left"><i class="fa fa-ln">&#xf054;</i> Next</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.5 Glossary
        </h3>
        
        <div data-role="collapsible-set" data-inset="true" data-theme="a" data-content-theme="b" id="glossaryCollection">
          <div data-role="collapsible" id="at-risk">
            <h3>
              At-risk patients
            </h3>
            <p>
              Please consult the list of indications to determine which patient groups
              are considered at risk of transfusion-associated <a href=
              "javascript:%20showWord('gvhd')" class="definition">Graft versus Host
              Disease</a> (TA-GvHD) and transfusion-transmitted <a href=
              "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV) infection.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="#list" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Indications</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="components">
            <h3>
              Blood components
            </h3>
            <p>
              Blood is separated into five components: red cells, platelets, white cells,
              fresh frozen plasma and cryoprecipitate <a href=
              "javascript:%20showSource('htm2007')" class="reference">HTM 2007, p. 1</a>.
              These can be classified into cellular and non-cellular (plasma) components.
            </p>
            <h3>
              Cellular blood components
            </h3>
            <p>
              Platelets, red cells and white cells are cellular blood components that
              contain leucocytes (white cells).
            </p>
            <p>
              Lymphocytes (a type of white cell) can cause <a href=
              "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a>. Hence
              cellular blood components, even if <a href=
              "javascript:%20showWord('leucodepletion')" class=
              "definition">leucodepleted</a>, must be <a href=
              "javascript:%20showWord('irradiation')" class="definition">irradiated</a>
              to deactivate any residual lymphocytes before transfusion to <a href=
              "javascript:%20showWord('at-risk')" class="definition">at-risk patients</a>
              <a href="javascript:%20showSource('htm2007')" class="reference">HTM 2007,
              p. 41</a>.
            </p>
            <p>
              The only exception to this rule is cryopreserved red cells after
              deglycerolization, because these are washed free of leucocytes <a href=
              "javascript:%20showSource('bcsh2010')" class="reference">BCSH 2010, p.
              42</a>.
            </p>
            <p>
              Monocytes (another type of white cell) may carry latent <a href=
              "javascript:%20showWord('cmv')" class="definition">cytomegalovirus</a>
              (CMV). For this reason SaBTO recommend cellular blood components be
              provided leucodepleted and CMV negative to high risk patients <a href=
              "javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012</a>.
            </p>
            <h3>
              Non-cellular (plasma) blood components
            </h3>
            <p>
              In contrast, fresh frozen plasma, cryoprecipitate or fractionated plasma
              products are non-cellular blood components that do not contain white cells.
            </p>
            <p>
              Non-cellular blood components do not need to be irradiated or provided as
              CMV negative (even though CMV can occurr freely in plasma) <a href=
              "javascript:%20showSource('sabto2012')" class="reference">SaBTO 2012, p.
              2</a>.
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="cmv">
            <h3>
              Cytomegalovirus (CMV)
            </h3>
            <p>
              "Cytomegalovirus is a herpes virus that gives rise to chronic, persistent
              and, for the most part, asymptomatic infection in a majority of adults
              worldwide. More severe disease may occur in certain groups, such as
              foetuses, neonates and immunocompromised adults." <a href=
              "javascript:%20showSource('sabto2012');" class="reference">SaBTO 2012</a>
            </p>
            <p>
              "Cytomegalovirus (CMV) infection can cause serious morbidity in
              immunocompromised CMV-negative patients. The risk can be minimised by the
              use of CMV-antibody-negative (seronegative) blood components. <a href=
              "javascript:%20showWord('leucodepletion')" class="definition">Leucocyte
              depletion</a> also confers some protection since the virus is associated
              with white blood cells." <a href="javascript:%20showSource('htm2007');"
              class="reference">HTM 2007, p. 41</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="relatives">
            <h3>
              First- or second-degree relatives
            </h3>
            <p>
      	      "The 'degree of relationship' describes the proportion of genes shared by two 
              blood relatives. A person's first degree relative is a parent, sibling,  or 
              child. A first degree relative shares about half of their genes with the person.
      	    </p>
      	    <p>
      	      A second degree relative of a person is an uncle, aunt, nephew, niece, 
              grandparent, grandchild or half- sibling.  A second degree relative shares about
              one quarter of their genes with the person." <a href="javascript:%20showSource('nhsgenetics');" class="reference">NHS NGGEC no year</a>.
            </p>
            <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="irradiation">
            <h3>
              Irradiation
            </h3>
            <p>
              "The major technology for preventing <a href=
              "javascript:%20showWord('gvhd')" class="definition">TA-GvHD</a> is
              irradiation of blood components to inactivate residual lymphocytes. Gamma
              rays and X-rays are similar in their ability to inactivate T lymphocytes in
              blood components at a given absorbed dose." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>
              "In the UK, a minimum of 25 Gy is recommended, but with the dose to any bag
              in the container not exceeding 50 Gy. To ensure this dose distribution is
              achieved, consultation with supporting physicists is mandatory." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.41</a>
            </p>
            <p>
              "For at-risk patients, all red cell, platelet and granulocyte concentrates
              should be irradiated except cryopreserved red cells after
              deglycerolization. It is not necessary to irradiate fresh frozen plasma,
              cryoprecipitate or fractionated plasma products (1B)." <a href=
              "javascript:%20showSource('bcsh2010');" class="reference">BCSH 2010,
              p.36</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="leucodepletion">
            <h3>
              Leucodepletion
            </h3>
            <p>
              Red cells and platelets supplied through the UK blood services are
              leucocyte depleted <a href="javascript:%20showSource('bcsh2010');" class=
              "reference">SaBTO 2012, p.1</a>.
            </p>
            <p>
              "Removal of leucocytes to a level of less than one million per component by
              filtration or during collection of blood components by apheresis is normal
              practice in a number of EU countries. Advantages of leucodepletion include
              a marked reduction in alloimmunisation to HLA antigens and in the risk of
              infection by intracellular viruses such as cytomegalovirus. Leucodepletion
              of red cells may also be associated with improved outcomes in some groups
              of patients." <a href="javascript:%20showSource('obu2010');" class=
              "reference">OBU 2010</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
          <div data-role="collapsible" id="gvhd">
            <h3>
              Transfusion-Associated Graft versus Host Disease
            </h3>
            <p>
              "TA-GvHD is a very rare but usually fatal complication following
              transfusion of lymphocyte-containing blood components. [---] The risk
              associated with an individual transfusion depends on the number and
              viability of contaminating lymphocytes, susceptibility of the
              recipient's immune system to their engraftment and degree of 
              immunological (HLA) disparity between donor and patient."
              <a href="javascript:%20showSource('bcsh2010');" class="reference">BCSH
              2010, p.37</a>
            </p>
            <p>
              "Transfused donor lymphocytes which are compatible with the recipient, but
              which recognise the recipient as foreign, can engraft and initiate TA-GvHD.
              Patients develop skin rash, diarrhoea and abnormal liver function, and
              deteriorate, with bone marrow failure and death from infection usually
              within two to three weeks of transfusion." <a href=
              "javascript:%20showSource('htm2007');" class="reference">HTM 2007, p.41</a>
            </p>
            <p>
              "Patients at risk are immunocompromised or those who receive transfusion
              from a first- or second-degree relative (due to the sharing of an HLA
              haplotype)." <a href="javascript:%20showSource('htm2007');" class=
              "reference">HTM 2007, p.62</a>
            </p><a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
            data-theme="b">Back</a>
          </div>
        </div>
        <p>
          Press to expand an entry.
        </p>
    
        <hr/>
        <a href="#learn4" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
        <a href="#learn6" data-role="button" data-theme="b" data-inline="true" class="active">Next <i class="fa fa-ln">&#xf054;</i></a>
       
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-role="page" id="learn6" data-title="Learn about Special Blood Components">
      
      <div data-role="header" data-position="fixed" data-tap-toggle="false" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf19d;</i> Learn: 1.6 References
        </h3>
        <div class="submenu inactive">
          <a href="#learn5" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>

      <div role="main" class="ui-content">
        
        <h3>
          1.6 References
        </h3>
        
        <div data-role="collapsible-set" data-theme="a" data-content-theme="b"
        data-inset="true" id="referenceCollection">
          <div data-role="collapsible" id="bcsh2010">
            <h3>
              BCSH (2010)
            </h3>
            <p>
              Treleaven, J., Gennery, A., Marsh, J., Norfolk, D., Page, L., Parker, A.,
              Saran, F., Thurston, J. and Webb, D. (2011), Guidelines on the use of
              irradiated blood components prepared by the British Committee for Standards
              in Haematology blood transfusion task force. British Journal of
              Haematology, 152: 35-51. doi: 10.1111/j.1365-2141.2010.08444.x
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08444.x/full"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="htm2007">
            <h3>
              HTM (2007)
            </h3>
            <p>
              DBL McClelland (ed) (2007) Handbook of Transfusion Medicine, 4th Ed.
              Published in the UK by The Stationary Office.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://www.transfusionguidelines.org.uk/index.aspx?Publication=HTM"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="mesh2013">
            <h3>
              MESH (2013)
            </h3>
            <p>
              Medical Subject Headings (2013) published by the U.S. National Library of
              Medicine, National Institutes of Health.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.nlm.nih.gov/mesh/2013/mesh_browser/" target="_blank"
                data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme=
                "b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="nhsgenetics">
            <h3>
              NHS NGGEC (no year)
            </h3>
            <p>
              NHS National Genetics and Genomics Education Centre,
              glossary item "First-degree relative".
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.geneticseducation.nhs.uk/genetics-glossary/181-first-degree-relative" target="_blank"
                data-icon="arrow-r" data-iconpos="right" data-role="button" data-theme=
                "b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="obu2010">
            <h3>
              OBU (2010)
            </h3>
            <p>
              McClelland DBL, Pirie E, Franklin IM (2010) for the EU Optimal Use of Blood
              Project Partners. The Optimal Blood Use Manual. Published by Scottish
              National Blood Transfusion Service.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.optimalblooduse.eu" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="sabto2012">
            <h3>
              SaBTO (2012)
            </h3>
            <p>
              Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)
              (2012) Position statement on cytomegalovirus tested blood components.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "https://www.gov.uk/government/publications/sabto-report-of-the-cytomegalovirus-steering-group"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2008">
            <h3>
              SHOT (2008)
            </h3>
            <p>
              Taylor C, Cohen H, Jones H, et al (2008), on behalf of the Serious Hazards
              of Transfusion (SHOT) Steering Group. The 2007 Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2007/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2009">
            <h3>
              SHOT (2009)
            </h3>
            <p>
              Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2009), on behalf of the
              Serious Hazards of Transfusion (SHOT) Steering Group. The 2008 Annual SHOT
              Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/reports-and-summaries-2008/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2010">
            <h3>
              SHOT (2010)
            </h3>
            <p>
              Taylor C (Ed.), Cohen H, Mold D, Jones H, et al (2010), on behalf of the
              Serious Hazards of Transfusion (SHOT) Steering Group. The 2009 Annual SHOT
              Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/report-and-summary-2009/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2012">
            <h3>
              SHOT (2012)
            </h3>
            <p>
              Bolton-Maggs, P (Ed) and Cohen, H (2012) on behalf of the Serious Hazards
              of Transfusion (SHOT) Steering Group. The 2011 Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="shot2013">
            <h3>
              SHOT (2013)
            </h3>
            <p>
              Bolton-Maggs P (Ed), Poles D, Watt A, Thomas D and Cohen H (2013) on behalf
              of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2012
              Annual SHOT Report.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href="http://www.shotuk.org/shot-reports/report-summary-and-supplement-2012/" target="_blank" data-icon=
                "arrow-r" data-iconpos="right" data-role="button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
          <div data-role="collapsible" id="ukbts2012">
            <h3>
              UKBTS (2012)
            </h3>
            <p>
              Joint UKBTS / HPA Professional Advisory Committee (2012) Position Statement
              on Granulocyte Therapy. Revised by Edwin Massey, Simon Stanworth and
              Rebecca Cardigan at the request of the Standing Advisory Committee on Blood
              Components.
            </p>
            <div class="ui-grid-a">
              <div class="ui-block-a">
                <a href="#" data-rel="back" data-icon="arrow-l" data-role="button"
                data-theme="b">Back</a>
              </div>
              <div class="ui-block-b">
                <a href=
                "http://www.transfusionguidelines.org.uk/index.aspx?Publication=DL&amp;pageid=1336"
                target="_blank" data-icon="arrow-r" data-iconpos="right" data-role=
                "button" data-theme="b">Open</a>
              </div>
            </div>
          </div>
        </div>
        <p>
          Press to expand an entry. All documents open in a new window.
        </p>
        
        <hr/>
        <a href="#learn5" data-role="button" data-theme="b" data-inline="true" data-rel="back" class="active"><i class="fa fa-ln">&#xf053;</i> Back</a>
       
      </div>
      
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
        <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab active"><i class="fa fa-2x glow">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab inactive"><i class="fa fa-2x">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    
    <div data-role="page" id="indications" data-title="Indications for irradiated and CMV negative blood components">
      <div data-role="header" class="inactive" data-theme="b">
        
        <h3 class="headerlogo active"><i class="fa fa-ln glow">&#xf0f1;</i> Indications for irradiated and CMV negative blood components
        </h3>
        <div class="submenu inactive">
          <a href="#" data-role="button" data-rel="back" class="float-left"><i class="fa fa-ln">&#xf053;</i> Back</a>
          <a href="#searchpanel" data-role="button">QuickFind <i class="fa fa-ln">&#xf002;</i></a>
        </div>
      </div>
      
      <div role="main" class="ui-content">

        <p>Determine if special blood components are required using the table. Press an indication to show details.</p>
         
          <div id="indications-filter">
            <button data-inline="true" onclick="$('#indicationsearch').toggle(); $('#indications-filter').toggle(); $('#close-indication-search').toggle();"><i class="fa fa-ln">&#xf002;</i> Search table</button>
            <select data-inline="true" class="fa-select" data-overlay-theme="b" data-theme="a" data-icon="false" data-native-menu="false">
              <option>&#xf0b0; Filter</option>
              <option>All indications</option>
              <option>&#xf043; Blood Components</option>
              <option>&#xf0c3; Immunosuppressive Drugs</option>
              <option>&#xf0f6; Medical History & Conditions</option>
              <option>&#xf1ae; Neonatology & Obstetrics</option>
              <option>&#xf0ec; Stem Cell & Bone Marrow Transplant</option>
            </select>
        </div>
      
        <div id="indicationsearch" class="hidden" style="background: #FFE; border:1px solid #ccc; border-radius: 5px; padding: 4px; margin-bottom: 1em;">
          <a href="#" style="float: right;" data-inline="true" data-role="button" class="hidden" id="close-indication-search" onclick="$('#indicationsearch').toggle(); $(this).toggle(); $('#indications-filter').toggle(); $('table').trigger('footable_clear_filter');">Clear <i class="fa fa-ln">&#xf00d;</i></a>
          <p><strong>Enter a search term:</strong></p>
          <input id="filter" type="text" />
          <a href="#" data-theme="b" class="hidden active" onclick="$('table').trigger('footable_filter', {filter: 'granulocyte'});" data-inline="true" data-role="button">Gran</a>

          <a href="#" data-theme="b" data-inline="true" data-role="button" class="hidden active" onclick=""><i class="fa fa-ln">&#xf002;</i> Search</a>
        </div>

        <table class="footable" id="indicationstable" data-filter="#filter">
          <thead>
            <tr>
              <th>
              </th>
              <th data-hide="all">
              </th>
              <th data-class="expand" class="centered">Indication
              </th>
              <th data-hide="phone" class="centered" data-type="numeric">Irradiation
              </th>
              <th data-hide="phone" class="centered" data-type="numeric">CMV-negative
              </th>
              <th data-hide="all" class="summary-guidance">
              </th>
              <th data-hide="all" class="referenced-guidance"></th>
            </tr>
          </thead>
          <tbody>
          </tbody>
        </table>
        <a href="#" data-role="button" data-theme="b" onclick="$(window).scrollTop(0);" class="active">Back to top <i class="fa fa-ln">&#xf0d8;</i></a>
      </div>
      <div data-role="footer" data-position="fixed" data-tap-toggle="false" data-theme="b">
       <div data-role="navbar">
          <ul>
            <li><a href="#home" class="navtab inactive"><i class="fa fa-2x">&#xf015;</i><br/>Home</a>
            </li>
            <li><a href="#learn" class="navtab inactive"><i class="fa fa-2x">&#xf19d;</i><br/>Rationale</a>
            </li>
            <li><a href="#indications" class="navtab active"><i class="fa fa-ln fa-2x glow">&#xf0f1;</i><br/>Indications</a>
            </li>
          </ul>
        </div>
      </div>
    </div>
    
    <div data-title="Special Blood Components" data-role="panel" id="searchpanel" data-position="right" data-display="overlay" data-animate="false" data-theme="a">
      <h3 style="margin: 0px;" class="centered">Search the app</h3>
      <label for="searchfield">Enter a search term or look up a word in the index:</label>
      <input data-theme="a" type="search" name="searchfield" id="searchfield" value="">
      <select data-theme="a" id="glossarylist" name="glossarylist" data-inline="true">
        <option value="">Press to show index terms</option>
        <option value="atrisk">At-risk patients</option>
        <option value="cellular">Blood components, cellular</option>
        <option value="non-cellular">Blood components, non-cellular</option>
        <option value="cmv">Cytomegalovirus</option>
        <option value="relative">First-degree relative</option>
        <option value="tagvhd">Graft vs. Host Disease</option>
        <option value="irradiation">Irradiation</option>
        <option value="ld">Leucodepletion</option>
        <option value="causes">Mistakes, causes of</option>
        <option value="mistakes">Mistakes, frequency of</option>
        <option value="prevention">Mistakes, preventing</option>
        <option value="relative">Second-degree relative</option>
        <option value="special">Special blood component</option>
        <option value="uld">Universal leucodepletion</option>
      </select> <a href="#" data-rel="close" data-icon="delete" data-role="button">Close</a>
    </div>
    
    <div data-title="Special Blood Components" data-role="panel" id="learningmenu" data-position="left" data-display="overlay" data-animate="false" data-theme="a">
      <h3 style="margin: 0px;" class="centered">Learning outline</h3>
      <a href="#learn" data-role="button">1.1 Learning objectives</a>
      <a href="#learn1" data-role="button">1.2 Introduction</a>
    </div>
    
        
    <div id="searchdialog" data-role="page">
  
  		<div data-role="header" class="active" data-theme="b">
  		  <h1>Search</h1>
  		</div>
  
  		<div role="main" class="ui-content">
    		<h4>Search the app</h4>
    		<form class="ui-filterable">
          <input id="autocomplete-input" data-type="search" placeholder="Search for a term...">
        </form>
        <ul data-role="listview" data-filter="true" data-filter-reveal="true" data-input="#autocomplete-input" data-inset="true">
            <li><a href="#">Apple</a></li>
            <li><a href="#">Banana</a></li>
            <li><a href="#">Cherry</a></li>
            <li><a href="#">Cranberry</a></li>
            <li><a href="#">Grape</a></li>
            <li><a href="#">Orange</a></li>
        </ul>
  			<a href="#" data-rel="back" class="ui-btn ui-shadow ui-corner-all ui-btn-a">Cancel</a>
  		</div>
  		
  	</div>
    
    
    <script src="http://code.jquery.com/jquery-1.11.1.min.js"></script>
    <script>
    
      
      $(document).on("mobileinit", function() {
        $.mobile.defaultPageTransition = 'none';
        $.mobile.gradeA = function() {
          
          // return ( ( $.support.mediaquery && $.support.cssPseudoElement ) || $.mobile.browser.oldIE && $.mobile.browser.oldIE >= 8 ) && ( $.support.boundingRect || $.fn.jquery.match(/1\.[0-7+]\.[0-9+]?/) !== null );
          
          // hack to force ie7 support again
          return true;
        };
            
      });
    </script>
    <script src="http://code.jquery.com/mobile/1.4.4/jquery.mobile-1.4.4.min.js"></script>
    <script src="footable.js" type="text/javascript"></script>
    <script src="app.js"></script>
  </body>

</html>